Innate Pharma Correlations

IPHA Stock  USD 1.82  0.03  1.62%   
The current 90-days correlation between Innate Pharma and Asure Software is 0.05 (i.e., Significant diversification). The correlation of Innate Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Innate Pharma Correlation With Market

Significant diversification

The correlation between Innate Pharma and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innate Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Innate Stock refer to our How to Trade Innate Stock guide.

Moving together with Innate Stock

  0.65PBCRY Bank Central AsiaPairCorr

Moving against Innate Stock

  0.58OBI Ondine BiomedicalPairCorr
  0.53SCLX Scilex HoldingPairCorr
  0.47OGN OrganonPairCorr
  0.44AMGN Amgen IncPairCorr
  0.42GILD Gilead SciencesPairCorr
  0.41BMY Bristol Myers SquibbPairCorr
  0.4600201 Jinyu Bio TechnologyPairCorr
  0.36CVS CVS Health CorpPairCorr
  0.33MRK Merck CompanyPairCorr
  0.33SCLXW Scilex HoldingPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CDNSASUR
CDNSHNFSB
HNFSBNAII
HNFSBPFODF
CDNSNNAVW
NNAVWHNFSB
  
High negative correlations   
WFCFHNFSB
WFCFNAII
CDNSWFCF
WFCFPFODF
WFCFASUR
WFCFNNAVW

Risk-Adjusted Indicators

There is a big difference between Innate Stock performing well and Innate Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Innate Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Innate Pharma Corporate Management

Odile BelzunceVice OperationsProfile
Marc BonnevilleFounderProfile
Jean FourniFounderProfile
Henry MScVice CommunicationProfile
DVM MBAVP FounderProfile
Sonia MDExecutive OfficerProfile